Arafat Hussein Al-Dujaili

IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation

Hussein Kadhem Al‐Hakeim, Duaa Abdulzahraa Al-Rammahi, Arafat Hussein Al-Dujaili · Journal of Affective Disorders · 2015 · 150 citations

Life Sciences, Immunology, Psychiatry +16

High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments

Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim et al. · Schizophrenia Bulletin · 2020 · 66 citations · Full text

Life Sciences, Neuroscience, Psychiatry +17

IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder

Suhaer Zeki Al-Fadhel, Hussein Kadhem Al‐Hakeim, Arafat Hussein Al-Dujaili et al. · European Psychiatry · 2019 · 48 citations · Full text

Medicine, Immunology, Psychiatry +15

Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

Hussein Kadhem Al‐Hakeim, Sadiq Neama Al-Kufi, Arafat Hussein Al-Dujaili et al. · CNS & Neurological Disorders - Drug Targets · 2018 · 35 citations

Veterinary Medicine, Immunology, Psychiatry +16

Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia

Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Arafat Hussein Al-Dujaili et al. · Current Topics in Medicinal Chemistry · 2020 · 35 citations · Full text

Medicine, Immunology, Psychiatry +14